However, to the best of our knowledge, GCPS is the only gene set which has now been validated in more than 700 stage II GC patients, regardless Lauren classification (diffuse or intestinal), a known prognostic factor, or adjuvant treatment. Here, GLI3 is linked to gastric cancer.